PSMA-Targeted Radiopharmaceuticals in Prostate Cancer: Current Data and New Trials

Radiopharmaceuticals have been utilized for men with advanced prostate cancer for decades. Older agents, seldom used today, provided palliation for bone metastatic pain. In 2013, the alpha emitter radium-223 provided a catalyst for the field by prolonging survival in men with metastatic castrate-res...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramnaraign, Brian, Sartor, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Genitourinary Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166155/
https://www.ncbi.nlm.nih.gov/pubmed/36806966
http://dx.doi.org/10.1093/oncolo/oyac279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166155/
https://www.ncbi.nlm.nih.gov/pubmed/36806966
http://dx.doi.org/10.1093/oncolo/oyac279

Ejemplares similares